Protalix Biotherapeutics Stock In The News
| PLX Stock | USD 1.71 0.02 1.18% |
Our overall analysis of Protalix Biotherapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Protalix Biotherapeutics. The specific impact of Protalix Biotherapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Protalix Biotherapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Protalix Biotherapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Protalix Biotherapeutics Backtesting and Protalix Biotherapeutics Hype Analysis. For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.
Protalix |
Protalix Biotherapeutics Today Top News and Investor Outlook
Protalix Biotherapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Protalix and other traded companies coverage with news coverage. We help investors stay connected with Protalix headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Protalix Stock performance. Please note that trading solely based on the Protalix Biotherapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Protalix Biotherapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Protalix earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Protalix Biotherapeutics that are available to investors today. That information is available publicly through Protalix media outlets and privately through word of mouth or via Protalix internal channels. However, regardless of the origin, that massive amount of Protalix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Protalix Biotherapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Protalix Biotherapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Protalix Biotherapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Protalix Biotherapeutics alpha.
Protalix Largest EPS Surprises
Earnings surprises can significantly impact Protalix Biotherapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-05-16 | 2022-03-31 | -0.04 | -0.05 | -0.01 | 25 | ||
2024-11-04 | 2024-09-30 | 0.06 | 0.03 | -0.03 | 50 | ||
2023-11-06 | 2023-09-30 | -0.07 | -0.04 | 0.03 | 42 | ||
2021-11-15 | 2021-09-30 | -0.12 | -0.09 | 0.03 | 25 | ||
2021-05-14 | 2021-03-31 | -0.17 | -0.14 | 0.03 | 17 | ||
2024-05-10 | 2024-03-31 | -0.02 | -0.06 | -0.04 | 200 |
Protalix Biotherapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Protalix Biotherapeutics Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
14th of November 2024
Earnings call Protalix BioTherapeutics reports strong Q3 growth at investing.com
7th of November 2024
Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on ... at finance.yahoo.com
23rd of September 2024
Acquisition by Yaron Naos of 100000 shares of Protalix Biotherapeutics at 1.1 subject to R... at MacroaxisInsider
4th of September 2024
Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment C... at finance.yahoo.com
30th of August 2024
Is Protalix BioTherapeutics, Inc. The Best Rated Penny Stock To Buy According to Analysts at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Protalix Biotherapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Protalix Biotherapeutics' short interest history, or implied volatility extrapolated from Protalix Biotherapeutics options trading.
Additional Tools for Protalix Stock Analysis
When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.